tradingkey.logo
搜尋

Biote Corp

BTMD
添加自選
2.250USD
+0.030+1.35%
收盤 07-31 16:00美東報價延遲15分鐘
69.03M總市值
4.47本益比TTM

關於 Biote Corp 公司

biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.

Biote Corp簡介

公司代碼BTMD
公司名稱Biote Corp
上市日期Mar 02, 2021
CEOChristensen (Bret)
員工數量217
證券類型Ordinary Share
年結日Mar 02
公司地址1875 W. Walnut Hill Ln #100
城市IRVING
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編75038
電話19724869346
網址https://haymakeracquisition.com/
公司代碼BTMD
上市日期Mar 02, 2021
CEOChristensen (Bret)

Biote Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Andrew R. (Andy) Heyer
Mr. Andrew R. (Andy) Heyer
Independent Director
Independent Director
2.48M
--
Ms. Mary Elizabeth Conlon
Ms. Mary Elizabeth Conlon
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
144.50K
--
Mr. Marc D. Beer
Mr. Marc D. Beer
Executive Chairman of the Board
Executive Chairman of the Board
107.79K
-250.48%
Mr. Bret Christensen
Mr. Bret Christensen
Chief Executive Officer, Principal Executive Officer, Director
Chief Executive Officer, Principal Executive Officer, Director
37.59K
--
Mr. Robert (Bob) Peterson
Mr. Robert (Bob) Peterson
Chief Financial Officer, Chief Business Officer
Chief Financial Officer, Chief Business Officer
--
--
Mr. Richard R. (Rich) Barrera
Mr. Richard R. (Rich) Barrera
Independent Director
Independent Director
--
--
Ms. Debra L. Morris
Ms. Debra L. Morris
Independent Director
Independent Director
--
--
Ms. Dana Jacoby
Ms. Dana Jacoby
Independent Director
Independent Director
--
--
Dr. S. Mark Cone
Dr. S. Mark Cone
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Andrew R. (Andy) Heyer
Mr. Andrew R. (Andy) Heyer
Independent Director
Independent Director
2.48M
--
Ms. Mary Elizabeth Conlon
Ms. Mary Elizabeth Conlon
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
144.50K
--
Mr. Marc D. Beer
Mr. Marc D. Beer
Executive Chairman of the Board
Executive Chairman of the Board
107.79K
-250.48%
Mr. Bret Christensen
Mr. Bret Christensen
Chief Executive Officer, Principal Executive Officer, Director
Chief Executive Officer, Principal Executive Officer, Director
37.59K
--
Mr. Robert (Bob) Peterson
Mr. Robert (Bob) Peterson
Chief Financial Officer, Chief Business Officer
Chief Financial Officer, Chief Business Officer
--
--
Mr. Richard R. (Rich) Barrera
Mr. Richard R. (Rich) Barrera
Independent Director
Independent Director
--
--

常見問題

Biote Corp的前五大股東是誰?

Biote Corp的前五大股東如下:Mr. Andrew R. (Andy) Heyer

有多少機構持有Biote Corp(BTMD)的股份?

截至2026Q1,共有214家機構持有Biote Corp的股份,合計持有的股份價值約為20.55M,占公司總股份的64.13% 。與2025Q4相比,機構持股有所增加,增幅為-2349533.00。

哪個業務部門對Biote Corp的收入貢獻最大?

在2026Q1,Pellet Procedures業務部門對Biote Corp的收入貢獻最大,創收137.04M,占總收入的71.29% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有